News and Trends 13 Jan 2016
A Phase II HIV Antiviral from France Has Promising Results
Abivax in Paris (France) has released its phase IIa clinical results for an antiviral therapy for patients with HIV infection, which could potentially take a corner in an annual $18Bn…